Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Stetler-Stevenson (2008)
Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological ActivitiesScience Signaling, 1
Li Yang, Haijuan Gu, Huaijun Zhu, Qingmin Sun, Rihong Cong, Bo Zhou, N. Tang, Bin Wang (2008)
Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 34 6
Yu‐Chiao Yi, Mu-Kuan Chen, Ling-yun Chen, E. Ho, Tsung-Ho Ying, P. Wang, Shun-Fa Yang (2009)
Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer.Clinica chimica acta; international journal of clinical chemistry, 409 1-2
A. Öberg, M. Höyhtyä, B. Tavelin, R. Stenling, G. Lindmark (2000)
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.Anticancer research, 20 2B
P. Srivastava, S. Pandey, B. Mittal, R. Mittal (2012)
No Association of Matrix Metalloproteinase [MMP]-2 (−735C > T) and Tissue Inhibitor of Metalloproteinase [TIMP]-2 (−418G > C) Gene Polymorphisms with Cervical Cancer SusceptibilityIndian Journal of Clinical Biochemistry, 28
Chun-Ying Wu, Ming-Shiang Wu, Yi-Ju Chen, Chien-Jen Chen, Hsiao-Ping Chen, C. Shun, Gran‐Hum Chen, Shih‐Pei Huang, Jaw-Town Lin (2007)
Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.European journal of cancer, 43 4
P. Srivastava, T. Lone, R. Kapoor, R. Mittal (2012)
Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.Archives of medical research, 43 2
J. Ross, P. Kaur, Christine Sheehan, H. Fisher, R. Kaufman, B. Kallakury (2003)
Prognostic Significance of Matrix Metalloproteinase 2 and Tissue Inhibitor of Metalloproteinase 2 Expression in Prostate CancerModern Pathology, 16
Yangfu Jiang, I. Goldberg, Y. Shi (2002)
Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 21
T. Hayakawa, K. Yamashita, E. Ohuchi, A. Shinagawa (1994)
Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2).Journal of cell science, 107 ( Pt 9)
K. Park, Seon Kim, Kyung Kim, Jin Kim (2011)
Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancerJournal of Gastroenterology and Hepatology, 26
Magdalena Groblewska, B. Mroczko, M. Gryko, A. Pryczynicz, K. Guzińska-ustyMowiCz, B. Kędra, A. Kemona, M. Szmitkowski (2014)
Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patientsTumour Biology, 35
E. Vairaktaris, C. Yapijakis, A. Yiannopoulos, S. Vassiliou, Z. Serefoglou, A. Vylliotis, E. Nkenke, S. Derka, E. Critselis, Dimitrios Avgoustidis, F. Neukam, E. Patsouris (2007)
Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans.Oncology reports, 17 4
H. Alakus, G. Grass, J. Hennecken, E. Bollschweiler, C. Schulte, U. Drebber, S. Baldus, R. Metzger, A. Hölscher, Stefan Mönig (2008)
Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.Histology and histopathology, 23 8
Caroline Alexander, Zena Werb (1992)
Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitroThe Journal of Cell Biology, 118
Y. Clerck, M. Darville, Y. Eeckhout, G. Rousseau (1994)
Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2).Gene, 139 2
M. Egeblad, Z. Werb (2002)
New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2
E. Gershtein, E. Korotkova, V. Prorokov, N. Kushlinsky (2008)
Matrix metalloproteinases 2, 3, 13 and their type 2 tissue inhibitor in tumors and plasma of patients with colorectal cancerBulletin of Experimental Biology and Medicine, 145
M. Larsen, Ross Stephens, Nils Brünner, Nils Brünner, Hans Nielsen, Lars Engelholm, I. Christensen, I. Christensen, W. Stetler-Stevenson, Gunilla Høyer-Hansen (2005)
Quantification of Tissue Inhibitor of Metalloproteinases 2 in Plasma from Healthy Donors and Cancer PatientsScandinavian Journal of Immunology, 61
N. Sounni, D. Rozanov, A. Remacle, V. Golubkov, A. Noel, A. Strongin (2009)
Timp‐2 binding with cellular MT1‐MMP stimulates invasion‐promoting MEK/ERK signaling in cancer cellsInternational Journal of Cancer, 126
Ming Zhang, Xiao-dan Teng, Xin-xin Guo, Zhigao Li, Jiguang Han, L. Yao (2013)
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.Breast, 22 3
D. Seo, Hongmei Li, L. Guédez, P. Wingfield, T. Diaz, Rita Salloum, Bei-yang Wei, W. Stetler-Stevenson (2003)
TIMP-2 Mediated Inhibition of Angiogenesis An MMP-Independent MechanismCell, 114
K. Hirano, T. Sakamoto, Y. Uchida, Y. Morishima, K. Masuyama, Y. Ishii, A. Nomura, Morio Ohtsuka, Kiyohisa Sekizawa (2001)
Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease.The European respiratory journal, 18 5
B. Ko, H. Cho, D. Choi, C. Nam, C. Park, G. Kim, S. Kim, Y. Woo, J. Huh, M. Kim (1998)
Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.Journal of Korean Medical Science, 13
J. Pérez-Gracia, C. Prior, F. Guillen-Grima, Victor Segura, Álvaro González, A. Panizo, Ignacio Melero, E. Grande-Pulido, A. Gúrpide, Ignacio Gil-Bazo, Alfonso Calvo (2009)
Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine arrayBritish Journal of Cancer, 101
Tissue inhibitors of metalloproteinases (TIMPs) appear to affect many aspects of cancer biology, playing a crucial role in cell signaling by regulating cell growth, apoptosis, invasion, metastasis, angiogenesis, and genomic instability. In the present study, we investigate whether TIMP-2 SNP, TIMP-2 mRNAs, and TIMP-2 protein is associated with susceptibility to colorectal cancer (CRC) in Tunisian population. Taqman and DNA sequencing techniques were used for genotyping, TIMP-2 expression of each genotype was analyzed using semiquantitative RT-PCR and TIMP-2 protein expression was analyzed using immunohistochemistry staining. Our results showed that significantly elevated CRC risk was found in individuals with CC genotype (odds ratio 1.959; 95% confidence interval, 1.055-3.637). Moreover TIMP-2 mRNA expression in the colorectal cell carcinomas was significantly higher compared with the normal colorectal tissue (0.487±0.015 vs. 0.210±0.013) (P<0.05). In addition, serum levels of TIMP-2 were significantly lower in CRC patients than in adenoma patients (P=0.01) and healthy controls (P=0.003). Serum levels of TIMP-2 correlated significantly with tumor stage and TNM stage and were the lowest in CRC patients with stage D,T4,(N1,N2,N3),M(+). In conclusion, our study demonstrate for the first time the distribution and the clinical significance of TIMP-2 promoter polymorphisms, mRNA, protein expression, and serum level in CRC Tunisian patients suggesting that the genotyping and serum level of TIMP-2 as potential markers for susceptibility to CRC will allow a precise and early identification of individuals at high risk and will aid the design of therapeutic modalities and evaluation of treatment outcome.
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Sep 1, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.